Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11377449 BTK inhibitors with improved dual selectivity

Overview Structured Data Issues Contributors Activity

All edits

Edits on 18 Oct, 2023

"update inverses"

edited on 18 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11786529 Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors

Edits on 19 Jul, 2023

"update inverses"

edited on 19 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors

0

Edits on 29 Apr, 2023

"update citations for inverse infoboxes"

edited on 29 Apr, 2023

Infobox

Patent Citations

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

0

Edits on 4 Apr, 2023

"Entity importer update"

edited on 4 Apr, 2023

Infobox

Is a

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

113774490

Date of Patent

July 5, 2022

0

Patent Application Number

166376150

Date Filed

August 12, 2018

0

Patent Citations

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

0

US Patent 10570139 Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

0

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Patent Citations Received

US Patent 11512132 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

Edits on 3 Apr, 2023

"update citations for inverse infoboxes"

edited on 3 Apr, 2023

Infobox

Patent Citations

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 30 Nov, 2022

"update inverses"

edited on 30 Nov, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11512132 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

0

Edits on 25 Sep, 2022

"update citations for inverse infoboxes"

edited on 25 Sep, 2022

Infobox

Patent Citations

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 24 Sep, 2022

"update citations for inverse infoboxes"

edited on 24 Sep, 2022

Infobox

Patent Citations

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

0

Edits on 23 Sep, 2022

"Entity importer update"

edited on 23 Sep, 2022

Infobox

Is a

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

113774490

Date of Patent

July 5, 2022

0

Patent Application Number

166376150

Date Filed

August 12, 2018

0

Patent Citations

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

0

US Patent 10570139 Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

0

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

Edits on 6 Jul, 2022

"Created via: Entity Importer"

created this topic on 6 Jul, 2022

Edits made to:

Infobox (+16 properties)

Article (+223 characters)

‌

US Patent 11377449 BTK inhibitors with improved dual selectivity

Article

Disclosed herein is a tri-substituted phenyl Btk inhibitors with improved dual selectivity, a method and a composition for inhibiting Btk and treating disease associated with undesirable Btk activity (Btk-related diseases).

Infobox

Is a

Patent jurisdiction

United States Patent and Trademark Office

Patent number

11377449

Date of patent

July 5, 2022

Patent application number

16637615

Date Filed

August 12, 2018

Patent citations

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

US Patent 10570139 Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

Patent primary examiner

CPC Code

Find more entities like US Patent 11377449 BTK inhibitors with improved dual selectivity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool